Financing Outlook for Florida Life Science and High Tech Companies: An Investor's Point of View
April 18, 2008
You have created a valuable intellectual property asset and assembled a core management team, and now it’s time to secure funding. In this session, a select group of investors and investment bankers in the high-tech and life sciences arena will tell you how they examine and analyze investment opportunities in this space. This discussion will focus on:
- Capital availability for Florida high-tech and life sciences companies (including impact of credit crunch)
- Areas of investor focus
- Lessons from recent deals
- Exit strategies
Related Insights
August 21, 2025
Innovative Technology Insights
Silicon, Sanctions and Security: How National Security Laws Are Reshaping the Semiconductor Industry
Nick O'Keefe and Christopher Swift break down how evolving U.S. regulations—CFIUS, FIRRMA, export controls, and outbound investment rules—are reshaping semiconductor deals, and highlighting risks and best practices for successful transactions.
August 21, 2025
Foley Viewpoints
Securing Value: Patent Strategies for AI-Accelerated Drug Repurposing
Drug development can be slow, costly, and risky, often taking more than a decade and billions of dollars to bring a single therapy to the…
August 21, 2025
Manufacturing Industry Advisor
Tariffs and Your Contracts: Why does the "importer of record" provision matter?
To ascertain which party in a commercial contract is responsible for tariffs, it is important to check whether the contract specifies the importer of record.